Anti-C5a Antibody (IFX-1) Treatment of Severe COVID-19: An Exploratory Phase 2 Randomized Controlled Trial
SSRN Electronic Journal (2020) - Comments
doi: 10.2139/ssrn.3658226  issn: 1556-5068 

Alexander P. J. Vlaar, Sanne De Bruin, Matthias Busch, Sjoerd Timmermans, Ingeborg E. Van Zeggeren, Rutger Koning, Liora Ter Horst, Esther B. Bulle, Frank E.H.P. Van Baarle, Marcel C.G. Van De Poll, E. Marleen Kemper, Iwan C.C. Van Der Horst, Marcus J. Schultz, Janneke Horn, Frederique Paulus, Lieuwe D. Bos, W. Joost Wiersinga, Martin Witzenrath, Simon Rueckinger, Korinna Pilz